Quidel | QDEL - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.7M 358K 2025-12
Avanos Medical USD 46.67M 216.61K 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bruker USD 152.22M 282K 2026-03
Charles River Laboratories USD 48.17M 1.05M 2026-03
Danaher USD 707.7M 800K 2026-03
Haemonetics USD 46.83M 82K 2025-12
Illumina USD 151.91M 893K 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Merit Medical Systems USD 59.65M 231K 2026-03
Mettler Toledo International USD 20.25M 179.94K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
Neogen USD 217.67M 147K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quidel USD 67.9M 0 2025-12
Revvity USD 111.8M 1.57M 2026-03
STAAR Surgical USD 49.78M 377K 2026-03
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Waters USD 98.17M 89K 2026-03